Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation

Experimental Cell Research

Volumn 316, Issue 7, 2010, Pages 1127-1136

  Nifuji, Akira ^a,b   Ideno, Hisashi ^a   Ohyama, Yoshio ^c   Takanabe, Rieko ^a   Araki, Ryoko ^a   Abe, Masumi ^a   Noda, Masaki ^c   Shibuya, Hiroshi ^c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TSURUMI UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone; Differentiation; Nemo like kinase; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEMO LIKE KINASE; OSTEOCALCIN; OSTEOPONTIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1; RETROVIRUS VECTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ANIMAL CELL; ARTICLE; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MESENCHYME CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WILD TYPE;

EID: 77950627936     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.01.023     Document Type: Article

References (31)

1. Ge C., Xiao G., Jiang D., Franceschi R.T. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell Biol. 2007, 176:709-718.
2. Schindeler A., Little D.G. Ras-MAPK signaling in osteogenic differentiation: friend or foe?. J. Bone Miner. Res. 2006, 21:1331-1338.
3. Mansukhani A., Bellosta P., Sahni M., Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 2000, 149:1297-1308.
4. Lai C.F., Chaudhary L., Fausto A., Halstead L.R., Ory D.S., Avioli L.V., Cheng S.L. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J. Biol. Chem. 2001, 276:14443-14450.
5. Hu Y., Chan E., Wang S.X., Li B. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 2003, 144:2068-2074.
6. Higuchi C., Myoui A., Hashimoto N., Kuriyama K., Yoshioka K., Yoshikawa H., Itoh K. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J. Bone Miner. Res. 2002, 17:1785-1794.
7. Choi K.W., Benzer S. Rotation of photoreceptor clusters in the developing Drosophila eye requires the nemo gene. Cell 1994, 78:125-136.
8. Brott B.K., Pinsky B.A., Erikson R.L. Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:963-968.
9. Ishitani T., Kishida S., Hyodo-Miura J., Ueno N., Yasuda J., Waterman M., Shibuya H., Moon R.T., Ninomiya-Tsuji J., Matsumoto K. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol. Cell Biol. 2003, 23:131-139.
10. Kanei-Ishii C., Ninomiya-Tsuji J., Tanikawa J., Nomura T., Ishitani T., Kishida S., Kokura K., Kurahashi T., Ichikawa-Iwata E., Kim Y., Matsumoto K., Ishii S. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 2004, 18:816-829.
11. Ishitani T., Ninomiya-Tsuji J., Matsumoto K. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol. Cell Biol. 2003, 23:1379-1389.
12. Ohkawara B., Shirakabe K., Hyodo-Miura J., Matsuo R., Ueno N., Matsumoto K., Shibuya H. Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction. Genes Dev. 2004, 18:381-386.
13. Zeng Y.A., Verheyen E.M. Nemo is an inducible antagonist of Wingless signaling during Drosophila wing development. Development 2004, 131:2911-2920.
14. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., Youn M.Y., Takeyama K., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y., Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K., Kato S. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell Biol. 2007, 9:1273-1285.
15. Dillon S.C., Zhang X., Trievel R.C., Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005, 6:227.
16. Yang L., Xia L., Wu D.Y., Wang H., Chansky H.A., Schubach W.H., Hickstein D.D., Zhang Y. Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 2002, 21:148-152.
17. Mal A., Harter M.L. MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1735-1739.
18. Kato Y., Kato M., Tachibana M., Shinkai Y., Yamaguchi M. Characterization of Drosophila G9a in vivo and identification of genetic interactants. Genes Cells 2008, 13:703-722.
19. Nifuji A., Noda M. Coordinated expression of noggin and bone morphogenetic proteins (BMPs) during early skeletogenesis and induction of noggin expression by BMP-7. J. Bone Miner. Res. 1999, 14:2057-2066.
20. Ideno H., Takanabe R., Shimada A., Imaizumi K., Araki R., Abe M., Nifuji A. Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro. Exp. Cell Res. 2009, 315:474-484.
21. Ishitani T., Ninomiya-Tsuji J., Nagai S., Nishita M., Meneghini M., Barker N., Waterman M., Bowerman B., Clevers H., Shibuya H., Matsumoto K. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 1999, 399:798-802.
22. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000, 7:1063-1066.
23. Komori T. Regulation of bone development and maintenance by Runx2. Front. Biosci. 2008, 13:898-903.
24. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
25. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 2002, 277:30998-31004.
26. Smit L., Baas A., Kuipers J., Korswagen H., van de Wetering M., Clevers H. Wnt activates the Tak1/Nemo-like kinase pathway. J. Biol. Chem. 2004, 279:17232-17240.
27. Wan M., Cao X. BMP signaling in skeletal development. Biochem. Biophys. Res. Commun. 2005, 328:651-657.
28. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 2006, 116:1202-1209.
29. Jin W., Takagi T., Kanesashi S.N., Kurahashi T., Nomura T., Harada J., Ishii S. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev. Cell 2006, 10:461-471.
30. Yasuda J., Yokoo H., Yamada T., Kitabayashi I., Sekiya T., Ichikawa H. Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB. Cancer Sci. 2004, 95:52-57.
31. Kurahashi T., Nomura T., Kanei-Ishii C., Shinkai Y., Ishii S. The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol. Biol. Cell 2005, 16:4705-4713.